Does Aeromonas hydrophila preferentially colonize the bowels of patients with hematologic malignancies?
Weekly cultures of stools from neutropenic patients and bone marrow transplant recipients yielded Aeromonas hydrophila from 8% of 88 patients over a 2-yr period. During this time stools in the routine enteric laboratory yielded A. hydrophila in 0.24% of 1632 patients. Although the patient groups and culture methods were not directly comparable, this significant difference in isolation rate (p less than 0.001) may reflect a higher colonization rate in the immunocompromised patient.
Sherlock
C H
CH
Division of Medical Microbiology, Vancouver General Hospital, B.C., Canada.
Burdge
D R
DR
Smith
J A
JA
D000328:Adult; D000333:Aeromonas / Q000302:isolation & purification*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000150:complications* / Q000188:drug therapy; D016026:Bone Marrow Transplantation; D005243:Feces / Q000382:microbiology; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications*; D008232:Lymphoproliferative Disorders / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000209:etiology
D000900:Anti-Bacterial Agents